Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
This video explores the evolving role of biomarkers in kidney cancer treatment, especially as more therapies become available for both metastatic and adjuvant settings. Key questions include which…
Donna, a long-time Huntington Beach resident, shares her journey living with non-small cell lung cancer (NSCLC). Diagnosed with the rare ERBB2 exon 20 mutation, she recounts the initial…
Multiple myeloma is a significant yet lesser-known type of blood cancer. In this Mayo Clinic Health System video, discover key insights about multiple myeloma, including its symptoms, prevalence,…
Stanford Cancer Center is offering new hope to melanoma patients through a groundbreaking cellular therapy called tumor infiltrating lymphocyte (TIL) therapy. This is the first approved cellular therapy…
This video explores the treatment of chronic myeloid leukemia (CML) in special populations. Dr. Mari Copland from the University of Glasgow covers considerations for managing CML in patients…
Jared Weiss, MD highlights the success of a grant that led to a patient’s first CAR infusion. Key topics include the importance of comprehensive biomarker testing in non-squamous…
John Connelly, MD from Chicago, Illinois, delves into the importance of chest radiographs in detecting lung cancer. Despite advancements in CT screenings, chest X-rays remain crucial for early…
This video features a presentation at the Best of Lung 2023 conference. Jaime Schneider, MD discusses the latest advancements in targeted therapies for lung cancer. They highlight the…
Watch the second day of the fourth annual Enco Alert Colloquium, a collaboration with top oncology societies. This event features leading experts discussing the latest in thoracic oncology…
Dr. Nicolas Girard, MD, PhD, explores new treatments for advanced HER2-positive non-small cell lung cancer (NSCLC). Highlighting the challenges faced by this orphan patient group, he discusses the…
